Fentanyl selector
PreclinicalSmall molecule
Fentanyl selector is one of 2 small molecule programs targeting Gynecologic Surgery. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
1
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
2 competitors in Gynecologic Surgery
#DrugCompanyPhaseTrials
1Acetominophen
Merck & Co.Preclinical
Fentanyl selector
SSeoul National University Bundang Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Fentanyl selector. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details